➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Medtronic
Harvard Business School
Baxter
AstraZeneca

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Patent: 10,011,643

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,011,643
Title:Freeze-dried preparation containing high-purity PTH and method for producing same
Abstract: [Problem] Provided is a freeze-dried preparation containing high-purity PTH peptide and a method for the production thereof. Also provided is a test method for PTH analogs to confirm the purity of a freeze-dried preparation containing PTH peptide, and the like. [Solution] In the present invention, the presence of PTH analogs produced during the manufacturing process of a freeze-dried preparation containing PTH peptide was confirmed. The production of these PTH analogs was also discovered to be markedly prevented or reduced by controlling exposure of the solution containing PTH peptide and the like to air environments within a pharmaceutical production facility.
Inventor(s): Nishio; Fumihide (Tokyo, JP), Maejima; Takuji (Tokyo, JP), Mitome; Yoshiro (Tokyo, JP)
Assignee: ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)
Application Number:14/990,948
Patent Claims:see list of patent claims

Details for Patent 10,011,643

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ⤷  Free Forever Trial ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) 2031-06-07 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ⤷  Free Forever Trial ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) 2031-06-07 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ⤷  Free Forever Trial ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) 2031-06-07 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ⤷  Free Forever Trial ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) 2031-06-07 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,011,643

Country Patent Number Estimated Expiration
China 103561757 ⤷  Free Forever Trial
China 104645318 ⤷  Free Forever Trial
China 108195965 ⤷  Free Forever Trial
European Patent Office 2719393 ⤷  Free Forever Trial
European Patent Office 3020409 ⤷  Free Forever Trial
European Patent Office 3170493 ⤷  Free Forever Trial
Spain 2761635 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Baxter
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.